Ann Collins

Ann (Cahill) Collins is an accomplished professional with extensive experience in clinical development and operations, particularly within oncology and hematology. Currently serving as the Global Program Lead for the PedAL Initiative at The Leukemia & Lymphoma Society and a Principal Consultant at Clinical Development Group, LLC, Ann has held prominent leadership roles at companies such as Aetion and Syneos Health. Notably, Ann has a strong track record of managing clinical operations and strategic initiatives, with a focus on improving clinical outcomes for cancer patients. Ann's educational background includes a PA-C degree from Yale School of Medicine and a BS from Duke University.